Health
Internal AstraZeneca safety report sheds light on neurological condition suffered by vaccine trial participant – CTV News
An internal safety report by pharmaceutical giant AstraZeneca describes how a participant in its vaccine trial developed trouble walking, weakness and pain in her arms, and other symptoms.
CNN has obtained an internal safety report by pharmaceutical giant AstraZeneca that sheds light on the neurological condition suffered by one of the participants in its coronavirus vaccine clinical trial.
The report details how the study volunteer, a previously healthy 37-year-old woman, “experienced confirmed transverse myelitis” after receiving her second dose of the vaccine, and was hospitalized on September 5.
Four days later, AstraZeneca dismissed media reports about the participant havin…
-
General16 hours agoAlleged Croydon Park gunman Artemios Mintzas charged with 25 offences
-
Noosa News24 hours agoPrime Minister Anthony Albanese calls for political temperature to be ‘turned down’ after alleged death threat
-
Noosa News23 hours agoYork family honours late son with tractor museum to fund cancer research
-
General22 hours agoTeam Australia wins back-to-back Motocross of Nations titles